PUBLISHER: The Business Research Company | PRODUCT CODE: 1948347
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948347
Topical absorbable hemostats are specialized medical products designed to aid the body's natural blood clotting during surgical procedures or traumatic bleeding. These agents are applied directly to bleeding areas and are formulated to be gradually broken down and absorbed by the body, eliminating the need for surgical removal.
The primary categories of topical absorbable hemostats include gelatin-based, collagen-based, fibrin-based, cellulose-based, and other types. Gelatin-based hemostats are derived from purified animal gelatin, typically sourced from pigs or cows. They are delivered through various forms such as surgical sprays, pads and gauzes, foams and films, and injectable solutions. These hemostats find applications in orthopedic, cardiothoracic, general, neurological, urological, and gynecological surgeries. Their main users include hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research institutions.
Tariffs are impacting the topical absorbable hemostats market by increasing import costs of raw materials and advanced hemostatic products, particularly affecting gelatin-based and collagen-based segments. Regions such as North America and Europe, which rely heavily on imported medical materials, have experienced price fluctuations and supply delays. While the tariffs have created cost pressures, they have also encouraged domestic manufacturing and local sourcing, potentially fostering innovation and development of cost-effective hemostatic solutions in the long term.
The topical absorbable hemostats market research report is one of a series of new reports from The Business Research Company that provides topical absorbable hemostats market statistics, including topical absorbable hemostats industry global market size, regional shares, competitors with a topical absorbable hemostats market share, detailed topical absorbable hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the topical absorbable hemostats industry. This topical absorbable hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The topical absorbable hemostats market size has grown strongly in recent years. It will grow from $2.17 billion in 2025 to $2.32 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing orthopedic and cardiothoracic surgeries, adoption of traditional hemostats, rising hospital infrastructure in developed regions, high prevalence of trauma and bleeding disorders, increasing awareness of surgical safety.
The topical absorbable hemostats market size is expected to see strong growth in the next few years. It will grow to $3.03 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to innovation in absorbable hemostatic materials, growth in minimally invasive surgeries, expansion of ambulatory surgical centers, rising geriatric population, demand for faster recovery and reduced hospital stays. Major trends in the forecast period include minimally invasive surgery adoption, surge in surgical procedures, rising focus on patient safety & reduced blood loss, growth in ambulatory surgical centers, development of biocompatible & fast-absorbing hemostats.
The growing number of surgical procedures is expected to drive the expansion of the topical absorbable hemostats market. Surgical procedures involve medically performed operations that include incisions or manipulation of body tissues to diagnose, treat, or improve health conditions. This rise in surgeries is mainly attributed to the increasing aging population, as older adults are more prone to chronic diseases and degenerative conditions that often require surgical intervention. Topical absorbable hemostats are beneficial during surgeries because they quickly control bleeding and do not need to be removed, which helps reduce operation time and lowers the risk of complications. For example, in June 2024, the International Society of Aesthetic Plastic Surgery, a US-based professional organization, reported that aesthetic procedures reached nearly 35 million in 2023, with total surgical and non-surgical procedures increasing by 3.4% to 34.9 million. Thus, the rising volume of surgical procedures is contributing to the growth of the topical absorbable hemostats market.
Key players in the topical absorbable hemostats market are focusing on developing innovative products such as absorbable hemostatic powders to better control bleeding in complex or irregular wound areas. These powders are preferred because they provide rapid bleeding control without needing removal, which reduces infection risks and simplifies post-operative care. For instance, in July 2023, Baxter International, a US-based healthcare company, introduced PERCLOT, an absorbable hemostatic powder. PERCLOT provides surgeons with a comprehensive range of active and passive hemostatic solutions to ensure effective bleeding management. Its specially designed granules absorb moisture almost immediately, forming an adhesive gel that physically seals tissue surfaces. This gel concentrates platelets, red blood cells, and clotting factors like thrombin and fibrinogen, speeding up the body's natural coagulation process. Reliable control of diverse intraoperative bleeding using PERCLOT can reduce transfusion needs, prevent major complications, and ultimately lower overall treatment costs.
In May 2023, Cousin Surgery, a France-based supplier of implantable medical devices, acquired PlantTec Medical for an undisclosed amount. This acquisition allows Cousin Surgery to broaden its cross-selling opportunities and enhance its research and development capabilities. It also adds a team with specialized expertise in surgical medical devices, strengthening the company's presence in the German market. PlantTec Medical is a Germany-based manufacturer of topical absorbable hemostats.
Major companies operating in the topical absorbable hemostats market are Johnson And Johnson Services Inc, Baxter International Inc, Integra LifeSciences Holdings Corp, Teleflex Inc, Gelita Medical, Advanced Medical Solutions Group Plc, 3D Matrix Ltd, Advanced Biotech Products Pvt Ltd, Curasan AG, Hemostasis LLC, Medcura Inc, Endomedix Incorporated, BioCer Entwicklungs GmbH, Starch Medical Inc, Arch Therapeutics Inc, Cura Medical BV, Z Medica LLC, Marine Polymer Technologies Inc, Ferrosan Medical Devices, Pfizer Hospital Products, Ethicon Biosurgery
North America was the largest region in the topical absorbable hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the topical absorbable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the topical absorbable hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The topical absorbable hemostats market consists of sales of flowable gelatin matrix agents, bioabsorbable composite hemostatic dressings, and dual-component hemostatic kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Topical Absorbable Hemostats Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses topical absorbable hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for topical absorbable hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The topical absorbable hemostats market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.